chelator

The chelator can have an effect on the kinetic rate and even the catalyzed reaction.

A chelator for binding a radioisotope can be attached.

Penicillamine is a pharmaceutical of the chelator class.

The rate of precipitation depends on the abundance and affinity of the chelator.

They are also inhibited by the chelator orthophenanthroline.

Vitamin C (ascorbic acid) itself can act as a chelator with iron or zinc, he explained.

Upon administration with a specific copper chelator, copper complexes would be formed at a relatively high level in tumors.

ATMP is a chemical compound used as a chelator.

Other results suggest that picolinic acid is a chelator which interacts with metals aside from zinc.

Because of this, it is possible that methanobactin may have several medical and environmental applications as a metal chelator and reducing agent.

Deferasirox (marketed as Exjade) is a rationally-designed oral iron chelator.

EDTA, commonly used as a food preservative, is also a typical chelator, he said.

The current evidence is comprised of many small non-comparative studies that evaluate the efficacy of a chelator in the short- or, more rarely, long-term.

A chelator or chelating agent is a molecule whose structure provides chemical "claws" to form bonds with a metal ion.

Salicylaldoxime is a chelator.

Manufacturers of avobenzone, like DSM recommend to include a chelator to prevent this from happening.

EDTA is a metal chelator that removes zinc, which is essential for activity.

This is important in light of the strong connection between the dose of the iron chelator and the amount of iron excreted.

Deferiprone is an iron chelator that is orally active, its administration thus being much easier than that for deferoxamine.

The antibody itself, nofetumomab, is attached to the chelator merpentan, which links it to the radioisotope technetium-99m (Tc).

Thus, this is evidence in favor of CB-TE2A as a bifunctional chelator without additional modification.

The oral chelator deferasirox (marketed as Exjade by Novartis) was approved for use in 2005 in some countries.

Each molecule of the tridentate chelator deferasirox binds to the iron at three sites, using one nitrogen atom and two oxygen atoms.

The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.

A commonly used synthetic chelator is ethylenediaminetetraacetic acid (EDTA).